(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro

The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

Mitsuya, H., Weinhold, K. J., Furman, P. A., Clair, M. H. S., Lehrman, S. N., Gallo, R. C., Bolognesi, D. P., Barry, D. W., & Broder, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7096 · Cited by 1,868

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

Pauwels, R., Balzarini, J. M., Baba, M., Snoeck, R., Schols, D., Herdewijn, P. A., Desmyter, J., & Clercq, E. D. (1988) · Journal of Virological Methods · doi:10.1016/0166-0934(88)90134-6 · Cited by 1,646

HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy

Larder, B. A., Darby, G., & Richman, D. D. (1989) · Science · doi:10.1126/science.2467383 · Cited by 1,559

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

Furman, P. A., Fyfe, J. A., St Clair, M. H., Weinhold, K., Rideout, J. L., Freeman, G. A., Lehrman, S. N., Bolognesi, D. P., Broder, S., & Mitsuya, H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8333 · Cited by 1,347

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.

Mitsuya, H., & Broder, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1911 · Cited by 1,041

ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

Yarchoan, R., Weinhold, K. J., Lyerly, H. K., Gelmann, E. P., Blum, R., Shearer, G. M., Mitsuya, H., Collins, J., Myers, C., Klecker, R. W., et al. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92808-4 · Cited by 802

Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase

Clair, M. H. S., Martin, J. L., Tudor‐Williams, G., Bach, M. C., Vavro, C., King, D. M., Kellam, P., Kemp, S. D., & Larder, B. A. (1991) · Science · doi:10.1126/science.1716788 · Cited by 678

PHASE I STUDIES OF 2',3'-DIDEOXYCYTIDINE IN SEVERE HUMAN IMMUNODEFICIENCY VIRUS INFECTION AS A SINGLE AGENT AND ALTERNATING WITH ZIDOVUDINE (AZT)

Yarchoan, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90283-8 · Cited by 506

In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine

Yarchoan, R., Mitsuya, H., Thomas, R. V., Pluda, J. M., Hartman, N. R., Perno, C. F., Marczyk, K. S., Allain, J., Johns, D. G., & Broder, S. E. (1989) · Science · doi:10.1126/science.2502840 · Cited by 422

Model Syntheses of Thiazolidine Nucleoside Analogues

Rassu, G., Zanardi, F., Cornia, M., & Casiraghi, G. (1996) · Nucleosides and Nucleotides · doi:10.1080/07328319608002037 · Cited by 7

First Synthesis And Antimicrobial Activity OfN- andS-α- L -Arabinopyranosyl-1,2,4-Triazoles

Khalil, N. S. A. M. (2007) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770701296986 · Cited by 6

Regioselective Suzuki–Miyaura reactions of 4,7-dichloro-N-methylisatin. Synthesis, anti-HIV activity and modeling study

Hamdy, A. M., Al-Masoudi, N. A., Pannecouque, C. C., Rahman, Q., Villinger, A., & Langer, P. (2015) · RSC Advances · doi:10.1039/c5ra16841d · Cited by 6

Nucleoside synthesis from 3-alkylated sugars: role of 3β-oxy substituents in directing nucleoside formation

Sahabuddin, S., Ghosh, R., Achari, B., & Mandal, S. B. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b514028e · Cited by 6

Synthesis of 2′,3′-Dideoxy-2′-Fluoro-l-threo-Pentofuranosyl Nucleosides as Potential Antiviral Agents

Cavalcanti, S. C. H., Xiang, Y., Newton, M. G., SCHINAZI, R. F., Cheng, Y.-C., & Chu, C. K. (1999) · Nucleosides and Nucleotides · doi:10.1080/07328319908044878 · Cited by 6

Template-competitive inhibitors of HIV-1 reverse transcriptase: design, synthesis and inhibitory activity

Li, K., Lin, W., Chong, K. H., Moore, B. M., II, & Doughty, M. B. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00297-8 · Cited by 6

Chemoenzymatic Production of the Antiviral Agent Epivir™

Mahmoudian, M., & Dawson, M. J. (1997) · Drugs and the pharmaceutical sciences · doi:10.1201/b14856-26 · Cited by 6

Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects

Huang, F., Allen, L., Huang, D. B., Moy, F. S., Vinisko, R., Nguyen, T., Rowland, L., MacGregor, T. R., Castles, M. A., & Robinson, P. A. (2010) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2010.01235.x · Cited by 5

The chemistry of L-nucleosides

Agrofoglio, L. A., & Challand, S. R. (1998) · Springer eBooks · doi:10.1007/978-94-007-0816-7_6 · Cited by 5

Zidovudine, Lamivudine, and Abacavir

Carten, M. L., & Kessler, H. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-085-0_2 · Cited by 4

Synthesis and antibacterial activity of 4-(1-naphthyl)-6-arylpyrimidin-2-(1H)-ones

Vijayaramalingam, K., Chandrasekaran, S., & Nagarajan, S. (2007) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-007-0056-8 · Cited by 4

2D 1H and 13C NMR evidence for stereoselective formation of a new bond C–N, C–S or C–C in the reaction of ivalin acetate with substituted pyrimidines

Dı́az, E., Nava, J. L., Barrios, H., Quiroz, B., Guzman, A., G., L. L., & B., A. F. (1998) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/s1386-1425(97)00245-x · Cited by 4

Electrospray tandem mass-spectrometric analysis of diastereo- and stereoisomeric pyrimidine nucleoside analogues based on the 1,3-dihydrobenzo[c]furan core

Len, C., Mackenzie, G., Ewing, D. F., Sheppard, G., & Banoub, J. H. (2003) · Carbohydrate Research · doi:10.1016/j.carres.2003.08.017 · Cited by 4

Asymmetric biosynthesis of intermediates of anti-HIV drugs

Wang, Y., Cao, Y., Li, Y., Jin, J., Li, J., & Song, H. (2017) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2017.04.008 · Cited by 4

Clevudine

Painter, G. R., Trost, L. C., Blum, M. R., Szczech, G. M., & Furman, P. A. (2003) · Elsevier eBooks · doi:10.1016/b978-044450986-4/50075-8 · Cited by 4

Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates

Wu, Y., Chmiel, A. F., & Bronson, J. J. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03492 · Cited by 3

OXATHIOLANE AND DIOXOLANE NUCLEOSIDES: SYNTHESIS AND ANTIVIRAL ACTIVITY

Gumina, G., Cooperwood, J. S., & Chu, C. K. (2003) · Elsevier eBooks · doi:10.1016/b978-044451319-9/50003-8 · Cited by 3

Immunomodulatory and Antiviral Activities of 2′,3′-Dideoxy-β-L-Cytidine and 2′,3′-Dideoxy-β-l-5-Fluorocytidine

Gagnon, L., Nordström, P., Duchaine, J., Jutras, D., Hamel, M., Barbeau, D. J., Hooker, E. U., Ashman, C., Cammack, N. C., Yuen, L., et al. (1995) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979509052717 · Cited by 3

Pharmacokinetics of lamivudine in cats

Zhang, W., Mauldin, J. K., Schmiedt, C. W., Brockus, C. W., Boudinot, F. D., & Stevenson, M. A. M. (2004) · American Journal of Veterinary Research · doi:10.2460/ajvr.2004.65.841 · Cited by 2

Synthesis and antiviral properties of novel analogues of monophosphate and diphosphate bioactive forms of acyclovir

Macchia, M., Antonelli, G., Bertini, S., Calvani, F., Bussolo, V. D., Minutolo, F., Tesoro, R., TONETTI, I., & Turriziani, O. (2000) · Il Farmaco · doi:10.1016/s0014-827x(00)00046-x · Cited by 2

Synthesis and antiviral activity of 2′-fluorohexopyranosyl nucleosides

Jeong, L. S., Lee, J. E., Kim, H. O., & Chun, M. W. (1998) · Archives of Pharmacal Research · doi:10.1007/bf02975298 · Cited by 1

Studies on the Metabolic Fate of Lamivudine (I): Absorption, Metabolism and Excretion of Lamivudine in Rats.

Takubo, T., MORIYA, T., Hirayama, S., Minamide, Y., Kato, T., NAKAMURA, R., & Kinami, J. (1997) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.12.85 · Cited by 1

HIV and the Mucosa: No Safe Haven

Dandekar, S., Sankaran, S., & Glavan, T. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8412-6_17 · Cited by 1

Mutations outside the YMDD motif in the P protein can also cause DHBV resistant to Lamivudine

He, J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i27.4261 · Cited by 1

Lamivudine in the Management of Adults with Human Immunodeficiency Virus Type 1 Infection

Moyle, G. J., & Gazzard, B. (1998) · Antiviral Therapy · doi:10.1177/135965359800300106 · Cited by 1

Selective targeting of the anti-viral agent lamivudine to the liver

Chimalakonda, K. C. (2007) · ThinkTech (Texas Tech University)

Intracellular Metabolism of Lamivudine

Zhou, Z., D’Argenio, D. Z., Robbins, B. L., & Rodman, J. H. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48523-0_2

Studies on the Metabolic Fate of Lamivudine (III): Absorption, Metabolism and Excretion of Lamivudine in Dogs.

Takubo, T., MORIYA, T., Minamide, Y., Hirayama, S., Kato, T., NAKAMURA, R., & Kinami, J. (1997) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.12.102

Randomized P hase I /II S tudy o f T roxacitabine C ombined W ith Cytarabine, I darubicin, o r T opotecan i n P atients W ith Refractory M yeloid L eukemias

Giles, F. J., Faderl, S. H., Thomas, D. A., Cortes, J. E., Garcia‐Manero, G., Douer, D., Levine, A. M., Koller, C. A., Jeha, S., Estey, E. H., et al. (2003)

AIDS.Spread condition, onset mechanism, prophylaxis and treatment of HIV infection and present condition of HIV research.

Nakajima, H. (1995) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.57.431

Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells

München, L.-M.-U. (2015)

Characterization of inducible reservoirs of HIV-1

Cillo, A. R. (2016) · D-Scholarship@Pitt (University of Pittsburgh)

Estudo epidemiológico e monitoramento de Lamivudina (3TC) e Zidovudina (AZT) na terapêutica do HIV-1 em pacientes de Belém – PA e suas correlações com as funções hepática, renal e nutricional, Belém, Pará

Barros, T. G. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Structural determinants of murine leukemia virus reverse transcriptase that are important for template switching, fidelity, and drug resistance

Svarovskaia, E. S. (2000) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.1239

Structural determinants of murine leukemia virus (MLV) reverse transcriptase (RT) important for fidelity and drug resistance in vivo

Halvas, E. K. (2000) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.1231

Faculty Opinions recommendation of Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies.

Ryoo, H. D. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733685711.793549102

N/A

N/A (2003) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v11.i11.1743

Versatile thiosugars in medicinal chemistry

Das, A., & Banik, B. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16164-3.00018-2

Synthesis and Resolution of 4′-Substituted Nucleosides with Potential Antiviral and Antisense Strategies

Endo, Y., Itoh, K., Kan‐no, H., Wakamatsu, H., Natori, Y., Saito, Y., Kaise, A., Nogi, Y., Saito–Tarashima, N., Minakawa, N., et al. (2025) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.4c02761

HIV Therapeutics: Antiretroviral Drugs and Immune-Based Therapies

Georgiev, V. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-297-1_34

The separated enantiomers of 2'-deoxy-3'-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro

Coates, J. A., Cammack, N. C., Jenkinson, H. J., Mutton, I. M., Pearson, B. A., Storer, R., Cameron, J. M., & Penn, C. R. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.202 · Cited by 288

Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro

Baba, M., Pauwels, R., Herdewijn, P. A., Clercq, E. D., Desmyter, J., & Vandeputte, M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90460-8 · Cited by 343

The separated enantiomers of 2′-deoxy-3′-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro. Antimicrobial Agents and Chemotherapy 36:202–205

Coates, J. A. V., Cammack, N., Jenkinson, H. J., Mutton, I. M., Pearson, B. A., Storer, R., Cameron, J. M., Charles, & Penn, R. (1992)

The biochemical basis for the differential anti-human immunodeficiency virus activity of two cis enantiomers of 2',3'-dideoxy-3'-thiacytidine.

Skalski, V., Chang, C. N., Dutschman, G. E., & Cheng, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49454-4 · Cited by 47

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

Schinazi, R. F., McMillan, A., Cannon, D. L., Mathis, R., Lloyd, R. M., Peck, A., Sommadossi, J., Clair, M. S., Wilson, J. G., & Furman, P. A. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.11.2423 · Cited by 295